Incubator at North Brunswick Tenants
Chrom-Matrix Inc. is an innovative chromatographic company primarily focused on the creation, development, manufacturing and supply of HPLC columns, sample preparation consumables, discovery methodology with outstanding performance for separation, analysis and purification of organic chemicals and biochemicals.
Couragene is leveraging its breakthrough delivery platforms to develop next-generation gene and biologic therapies. Couragene harnesses its innovative technologies to create novel therapeutics via non-viral delivery of genome editing machinery, DNA/RNA, and other biologics. Furthermore, Couragene has discovered and developed proprietary materials for oral delivery of therapeutic agents.
Delve Therapeutics is a discovery-stage startup researching novel oncolytic viruses.
Fidelis Pharmaceuticals is a commercial stage, animal health company that provides GMP pharmaceuticals formulated specifically for laboratory animals
HistoBridge is a specialty preclinical and clinical research services organization committed to fulfill the histology and pathology needs for drug discovery/development.
Innovative Molecules is a drug discovery and contract research services company that will apply organic chemistry and biochemistry to optimize the pharmacotherapeutic utility of medicinal compounds.
JMS Pharma is a pharmaceutical contract development and manufacturing organization (CDMO) with focus on developing sterile formulations.”
Linus Biotechnology Inc.
LinusBio is a patient-centric, precision exposome medicine company.
Originating from the world’s leading exposome laboratory at Mount Sinai Health System, Linus has developed a technology platform that builds on breakthroughs in exposome sequencing by trailblazing researchers Drs. Manish Arora, Christine Austin and Paul Curtin.
The Company’s program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology.
Neoventech strives to be the recognized leader in topical drug and active cosmetic product development. Our dedicated R&D team has a combined of 70+ years’ experience in drug delivery, cosmetic and topical drug product development and their successful global commercialization. The mission is to assist you to transform innovative ideas into successful cosmetics or topicalpharmaceutical products to address the dermatological disorders and unmet consumer needs in skin health. Neoventech commits to partner with industrial leaders and to find better ways to deliver the high quality products and services in a timely manner.
OLI Technologies is revolutionizing end-stage renal disease treatment. Leveraging proprietary nanotechnologies, OLI is developing intelligent wearables that emulate the natural capabilities of healthy kidneys.
Osseoprint 3D has developed a proprietary platform to design 3D print patient-matched bone scaffolds for fast and simple bone reconstruction surgeries. Orthopedic, dental, cosmetic, and other surgeons can augment and reconstruct bone defects with precision, speed, and safety with this chair-side 3D printing technology.
Quintara LLC is a biotechnology and bioinformation service company. The company will provide DNA sequencing, DNA synthesis, cloning, gene editing, and DNA genomic data analysis. The target markets are university research labs, and biotechnology companies in the NYC metro area.
Skunkworx Labs (SKWX) is an innovative biologic drug discovery company dedicated to creating therapeutics targeting cancer, inflammation, and infectious diseases. Our unique protein screening platforms provide greater combinatory diversity than what naturally occurs in nature. It reaches beyond visible biology producing truly synthetic possibilities. SKWX serves to fix biological problems by providing synthetic solutions through its NanoProtein and NanoAntibody Libraries. Skunkworx can generate candidate biologics from known and unknown targets, identify new targets and generate tools and agents to guide rational drug design.
Smirta Innovation Inc.
Smirta Innovations Inc. is a Digital Health company focused on bringing Machine learning and AI based platforms to optimize patient flow logistics within Cancer treatment Centers as well as assist pathologists in analyzing tissues to segment, measure and predict. Smirta Innovations is led by an experienced group of Health IT executives and physicians who have successfully developed and commercialized multiple Health IT products that were used by large Health Systems nationwide.
SPES Pharmaceuticals is an innovative pharmaceutical technology company dedicated to provide medications with improved clinical benefits and patient compliance through development of innovative formulation and drug delivery technologies.
Sonder Research X
Sonder Medicine Inc. is a biotechnology startup company focused on using advanced imaging technology to develop therapeutic solutions for ophthalmic diseases and cancer, exclusively licensed from Cornell University
TheWell Bioscience is a biotech company focusing to develop and commercialize novel cell culture and delivery systems to empower life science research. Our goal is to bridge the in vitro and in vivo studies with simple, versatile products and services to achieve better efficiency while reducing costs. A joyful spirit is a precious gift to us.